[{"address1": "535 W 24th Street", "address2": "5th Floor", "city": "New York", "state": "NY", "zip": "10011", "country": "United States", "phone": "855 508 3568", "website": "https://www.neurogene.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreements with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.", "fullTimeEmployees": 107, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rachel L. McMinn Ph.D.", "age": 52, "title": "Founder, Executive Chair & CEO", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 929410, "exercisedValue": 0, "unexercisedValue": 249075}, {"maxAge": 1, "name": "Ms. Christine Mikail Cvijic J.D.", "age": 47, "title": "President & CFO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 746750, "exercisedValue": 0, "unexercisedValue": 1035052}, {"maxAge": 1, "name": "Dr. Julie  Jordan M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 651036, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stuart  Cobb Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 478807, "exercisedValue": 0, "unexercisedValue": 338906}, {"maxAge": 1, "name": "Ms. Donna M. Cochener-Metcalfe J.D., L.L.M.", "age": 49, "title": "Senior VP & General Counsel", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew E. Mulberg CPI, FAAP, M.D.", "title": "Senior Vice President of Regulatory Affairs, Quality Assurance & Quality Control", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ricardo  Jimenez", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Arvind  Sreedharan", "title": "Senior Vice President of Business Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 18.62, "open": 18.38, "dayLow": 17.32, "dayHigh": 18.51, "regularMarketPreviousClose": 18.62, "regularMarketOpen": 18.38, "regularMarketDayLow": 17.32, "regularMarketDayHigh": 18.51, "payoutRatio": 0.0, "beta": 2.041, "forwardPE": -3.8515284, "volume": 177712, "regularMarketVolume": 177712, "averageVolume": 163815, "averageVolume10days": 111370, "averageDailyVolume10Day": 111370, "bid": 12.99, "ask": 22.59, "bidSize": 2, "askSize": 2, "marketCap": 273240064, "fiftyTwoWeekLow": 6.875, "fiftyTwoWeekHigh": 37.266, "allTimeHigh": 1115.0, "allTimeLow": 6.875, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 18.984, "twoHundredDayAverage": 20.830826, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 18038072, "profitMargins": 0.0, "floatShares": 5049520, "sharesOutstanding": 15489800, "sharesShort": 3591099, "sharesShortPriorMonth": 3502155, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.2318, "heldPercentInsiders": 0.085439995, "heldPercentInstitutions": 1.09391, "shortRatio": 23.37, "shortPercentOfFloat": 0.2881, "impliedSharesOutstanding": 15489800, "bookValue": 17.972, "priceToBook": 0.9815268, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -85130000, "trailingEps": -4.1, "forwardEps": -4.58, "lastSplitFactor": "1:4", "lastSplitDate": 1702944000, "enterpriseToEbitda": -0.191, "52WeekChange": 0.0017291307, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 17.64, "targetHighPrice": 70.0, "targetLowPrice": 46.0, "targetMeanPrice": 57.2, "targetMedianPrice": 50.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 265410000, "totalCashPerShare": 17.135, "ebitda": -94208000, "totalDebt": 10208000, "quickRatio": 18.101, "currentRatio": 18.39, "totalRevenue": 0, "debtToEquity": 3.844, "revenuePerShare": 0.0, "returnOnAssets": -0.26914, "returnOnEquity": -0.42253, "grossProfits": -69719000, "freeCashflow": -47322124, "operatingCashflow": -77240000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "NGNE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1771625376, "regularMarketTime": 1771621201, "exchange": "NGM", "messageBoardId": "finmb_602062523", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -5.26317, "regularMarketPrice": 17.64, "shortName": "Neurogene Inc.", "longName": "Neurogene Inc.", "earningsTimestampStart": 1774299600, "earningsTimestampEnd": 1774299600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.1, "epsForward": -4.58, "epsCurrentYear": -4.19, "priceEpsCurrentYear": -4.210024, "fiftyDayAverageChange": -1.3439999, "fiftyDayAverageChangePercent": -0.07079645, "twoHundredDayAverageChange": -3.1908264, "twoHundredDayAverageChangePercent": -0.15317811, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1394202600000, "postMarketChangePercent": 0.0, "postMarketPrice": 17.64, "postMarketChange": 0.0, "regularMarketChange": -0.980001, "regularMarketDayRange": "17.32 - 18.51", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 163815, "fiftyTwoWeekLowChange": 10.764999, "fiftyTwoWeekLowChangePercent": 1.5658181, "fiftyTwoWeekRange": "6.875 - 37.266", "fiftyTwoWeekHighChange": -19.626, "fiftyTwoWeekHighChangePercent": -0.52664626, "fiftyTwoWeekChangePercent": 0.17291307, "displayName": "Neurogene", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]